![Pierre Sayad](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortune : 208 679 $ au 31/05/2026
Pierre S.
Sayad is currently Chief Medical Officer at Fennec Pharmaceuticals, Inc. since 2024.
Formerly, Dr. Sayad was Senior Vice President-Global Medical Affairs at International Myeloma Foundation, Vice President-Global Medical & Scientific Affairs at Karyopharm Therapeutics, Inc., and Chief Operating & Medical Officer at Zephyr Group, Inc. Education includes graduate studies at Loma Linda University and undergraduate studies at San Jose State University.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 01/06/2026 | 21 015 ( 0,06% ) | 208 679 $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| FENNEC PHARMACEUTICALS INC. | Directeur Technique/Scientifique/R&D | 28/10/2024 |
| Sociétés | Poste | Fin |
|---|---|---|
International Myeloma Foundation
 International Myeloma Foundation Miscellaneous Commercial ServicesCommercial Services Supports myeloma patients | Corporate Officer/Principal | - |
| KARYOPHARM THERAPEUTICS INC. | Directeur Technique/Scientifique/R&D | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 5 |
|---|---|
Fennec Pharmaceuticals, Inc.
 Fennec Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops and commercializes therapeutic products which dedicated to improving the lives of children with cancer who experience hearing loss | Health Technology |
International Myeloma Foundation
International Myeloma Foundation Miscellaneous Commercial ServicesCommercial Services Supports myeloma patients | Commercial Services |
Loma Linda University
 Loma Linda University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
San Jose State University
 San Jose State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Karyopharm Therapeutics, Inc.
 Karyopharm Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops novel drugs for the treatment of cancer, inflammation and other diseases related to cell proliferation | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
